Clinical Trial Update: Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating thalidomide and prednisone after autologous stem cell transplantation in multiple myeloma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2020-10-05